Unlocking true 3D cell culture

Our biomimetic GelMA hydrogels provide an optimized extracellular matrix, enabling enhanced cell viability, spreading, and reproducibility in 3D culture systems.

Why choose us?


 

3D Models for Physiological Relevance

Replicating native human tissue architecture with organ-on-a-chip platforms, delivering more predictive and physiologically relevant results for drug discovery and disease modeling.

Optimized Hydrogels for 3D Cell Culture

Our GelMA hydrogels ensure unmatched batch-to-batch consistency, high cytocompatibility, and superior performance for primary cells, iPSCs, and organoids in 3D culture systems.

A Decade of Organ-on-a-Chip Expertise

With over 10 years of OOC innovation, we provide fully customized solutions—from microfluidic chip design to integrated perfusion systems—tailored to accelerate your research.

Our Core Products

Cutting-edge Tools for 3D Biology

From hydrogels to organ-on-a-chip systems, our products empower next-generation cell culture, modeling, and drug discovery.

Hydrogels

  • GelMA & HAMA bioinks for 3D culture
  • Batch-to-batch consistency
  • High cytocompatibility
  • Support iPSCs, primary cells, organoids

Organ-on-a-chip

  • Integrated tissue culture with perfusion
  • Real-time monitoring compatibility
  • Physiological relevance close to in vivo
  • Proven applications in disease models

Mircofluidic chip

  • Customizable microchannel design
  • Optical & fluidic compatibility
  • For single- & multi-organ modeling
  • Scalable for drug testing

Customized products

  • Tailored chip design & hydrogel kits
  • Integration with lab hardware
  • Consulting & training support
  • Full-stack R&D service
Innovators Behind NEOgran

OUR SCIENTIFIC FOUNDERS

Combining science, engineering, and vision to drive innovation.

Robin Wu

CTO, co-founder
Principal Investigator Marie Skłodowska-Curie Actions (MSCA) Fellow 15 years expertise in Biomaterials and Organ-on-a-chip.

Tinee Li

CSO, co-founder
Organ-on-a-Chip research
Extensive publication record in microfluidics and tissue engineering.

Lynette Wang

CEO, co-founder
10 years expertise in materials–cell interactions
Specialist in strategy, partnerships, and industry translation.

We are waiting for your questions!

We are always open to you, feel free to communicate with our team